The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by CAMP/PKA and CGMP/PKG in Anucleate Human Platelets

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2020 Feb 23

PMID 32085646

Citations 13

Authors

Elena J Kumm

Oliver Pagel

Stepan Gambaryan

Ulrich Walter

Rene P Zahedi

Albert Smolenski

Kerstin Jurk

Affiliations

Soon will be listed here.

Abstract

The cell cycle is controlled by microtubule-associated serine/threonine kinase-like (MASTL), which phosphorylates the cAMP-regulated phosphoproteins 19 (ARPP19) at S62 and 19e/α-endosulfine (ENSA) at S67and converts them into protein phosphatase 2A (PP2A) inhibitors. Based on initial proteomic data, we hypothesized that the MASTL-ENSA/ARPP19-PP2A pathway, unknown until now in platelets, is regulated and functional in these anucleate cells. We detected ENSA, ARPP19 and various PP2A subunits (including seven different PP2A B-subunits) in proteomic studies of human platelets. ENSA-S109/ARPP19-S104 were efficiently phosphorylated in platelets treated with cAMP- (iloprost) and cGMP-elevating (NO donors/riociguat) agents. ENSA-S67/ARPP19-S62 phosphorylations increased following PP2A inhibition by okadaic acid (OA) in intact and lysed platelets indicating the presence of MASTL or a related protein kinase in human platelets. These data were validated with recombinant ENSA/ARPP19 and phospho-mutants using recombinant MASTL, protein kinase A and G. Both ARPP19 phosphorylation sites S62/S104 were dephosphorylated by platelet PP2A, but only S62-phosphorylated ARPP19 acted as PP2A inhibitor. Low-dose OA treatment of platelets caused PP2A inhibition, diminished thrombin-stimulated platelet aggregation and increased phosphorylation of distinct sites of VASP, Akt, p38 and ERK1/2 MAP kinases. In summary, our data establish the entire MASTL(like)-ENSA/ARPP19-PP2A pathway in human platelets and important interactions with the PKA, MAPK and PI3K/Akt systems.

Citing Articles

KIF2A Upregulates PI3K/AKT Signaling through Polo-like Kinase 1 (PLK1) to Affect the Proliferation and Apoptosis Levels of Spermatogenic Cells.

Zhao Y, Liu D, Tan F, Yang W Biology (Basel). 2024; 13(3).

PMID: 38534420 PMC: 10968087. DOI: 10.3390/biology13030149.

Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets.

Zhang P, Solari F, Heemskerk J, Kuijpers M, Sickmann A, Walter U Int J Mol Sci. 2023; 24(9).

PMID: 37175486 PMC: 10178361. DOI: 10.3390/ijms24097776.

The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function.

Gambaryan S Cells. 2022; 11(22).

PMID: 36429131 PMC: 9688146. DOI: 10.3390/cells11223704.

Quantifying and mathematical modelling of the influence of soluble adenylate cyclase on cell cycle in human endothelial cells with Bayesian inference.

Woranush W, Moskopp M, Noll T, Dieterich P J Cell Mol Med. 2022; 26(23):5887-5900.

PMID: 36372953 PMC: 9716222. DOI: 10.1111/jcmm.17611.

Novel Variant Causing a Bleeding Phenotype Associated with Combined Platelet α-/δ-Storage Pool Deficiency and Mild Dyserythropoiesis Modified by a Variant.

Jurk K, Adenaeuer A, Sollfrank S, Gross K, Hauser F, Czwalinna A Cells. 2022; 11(19).

PMID: 36231035 PMC: 9564339. DOI: 10.3390/cells11193071.

References

Schmitz M, Held M, Janssens V, Hutchins J, Hudecz O, Ivanova E . Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol. 2010; 12(9):886-93. PMC: 3839080. DOI: 10.1038/ncb2092. View

Packham M, Livne A, Ruben D, Rand M . Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic.... Biochem J. 1993; 290 ( Pt 3):849-56. PMC: 1132359. DOI: 10.1042/bj2900849. View

Jurk K . Analysis of platelet function and dysfunction. Hamostaseologie. 2014; 35(1):60-72. DOI: 10.5482/HAMO-14-09-0047. View

Benz P, Laban H, Zink J, Gunther L, Walter U, Gambaryan S . Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets. Cell Commun Signal. 2016; 14(1):21. PMC: 5020514. DOI: 10.1186/s12964-016-0144-z. View

Sangodkar J, Farrington C, McClinch K, Galsky M, Kastrinsky D, Narla G . All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase. FEBS J. 2015; 283(6):1004-24. PMC: 4803620. DOI: 10.1111/febs.13573. View

Gharbi-Ayachi A, Labbe J, Burgess A, Vigneron S, Strub J, Brioudes E . The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science. 2010; 330(6011):1673-7. DOI: 10.1126/science.1197048. View

Janssens V, Goris J, Van Hoof C . PP2A: the expected tumor suppressor. Curr Opin Genet Dev. 2005; 15(1):34-41. DOI: 10.1016/j.gde.2004.12.004. View

Heemskerk J, Harper M, Cosemans J, Poole A . Unravelling the different functions of protein kinase C isoforms in platelets. FEBS Lett. 2011; 585(12):1711-6. DOI: 10.1016/j.febslet.2011.05.017. View

Beck F, Geiger J, Gambaryan S, Solari F, DellAica M, Loroch S . Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood. 2017; 129(2):e1-e12. PMC: 5248936. DOI: 10.1182/blood-2016-05-714048. View

10.

Vanhoutte P, Shimokawa H, Feletou M, Tang E . Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol (Oxf). 2015; 219(1):22-96. DOI: 10.1111/apha.12646. View

11.

Makhoul S, Walter E, Pagel O, Walter U, Sickmann A, Gambaryan S . Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets. Nitric Oxide. 2018; 76:71-80. DOI: 10.1016/j.niox.2018.03.008. View

12.

Manning G, Whyte D, Martinez R, Hunter T, Sudarsanam S . The protein kinase complement of the human genome. Science. 2002; 298(5600):1912-34. DOI: 10.1126/science.1075762. View

13.

Labandera A, Vahab A, Chaudhuri S, Kerk D, Moorhead G . The mitotic PP2A regulator ENSA/ARPP-19 is remarkably conserved across plants and most eukaryotes. Biochem Biophys Res Commun. 2015; 458(4):739-44. DOI: 10.1016/j.bbrc.2015.01.123. View

14.

Versteeg H, Heemskerk J, Levi M, Reitsma P . New fundamentals in hemostasis. Physiol Rev. 2013; 93(1):327-58. DOI: 10.1152/physrev.00016.2011. View

15.

Wang X, Bajaj R, Bollen M, Peti W, Page R . Expanding the PP2A Interactome by Defining a B56-Specific SLiM. Structure. 2016; 24(12):2174-2181. PMC: 5180209. DOI: 10.1016/j.str.2016.09.010. View

16.

Voets E, Wolthuis R . MASTL is the human orthologue of Greatwall kinase that facilitates mitotic entry, anaphase and cytokinesis. Cell Cycle. 2010; 9(17):3591-601. DOI: 10.4161/cc.9.17.12832. View

17.

Offermanns S . Activation of platelet function through G protein-coupled receptors. Circ Res. 2006; 99(12):1293-304. DOI: 10.1161/01.RES.0000251742.71301.16. View

18.

Mochida S, Maslen S, Skehel M, Hunt T . Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science. 2010; 330(6011):1670-3. DOI: 10.1126/science.1195689. View

19.

Abel K, Mieskes G, Walter U . Dephosphorylation of the focal adhesion protein VASP in vitro and in intact human platelets. FEBS Lett. 1995; 370(3):184-8. DOI: 10.1016/0014-5793(95)00817-s. View

20.

Castro A, Lorca T . Greatwall kinase at a glance. J Cell Sci. 2018; 131(20). DOI: 10.1242/jcs.222364. View